| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 108.68  |
1-year : | 126.94 |
| Resists | First : | 93.05 |
Second : | 108.68 |
| Pivot price | 88.08 |
|||
| Supports | First : | 87 |
Second : | 83.26 |
| MAs | MA(5) : | 90.46 |
MA(20) : | 87.25 |
| MA(100) : | 86.05 |
MA(250) : | 86.13  |
|
| MACD | MACD : | 1.5 |
Signal : | 1 |
| %K %D | K(14,3) : | 98.4 |
D(3) : | 94.8 |
| RSI | RSI(14): 70.5 |
|||
| 52-week | High : | 104.57 | Low : | 70.93 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ LMAT ] has closed above the upper band by 7.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 35.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 93.11 - 93.38 | 93.38 - 93.69 |
| Low: | 90.4 - 90.74 | 90.74 - 91.12 |
| Close: | 92.34 - 92.85 | 92.85 - 93.43 |
Sat, 21 Feb 2026
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen - MarketBeat
Fri, 20 Feb 2026
LeMaitre Vascular (LMAT) Analyst Ratings Maintain 'Outperform' w - GuruFocus
Fri, 20 Feb 2026
Barrington Research Reaffirms "Outperform" Rating for LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat
Wed, 18 Feb 2026
Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns? - simplywall.st
Sat, 14 Feb 2026
Behavioral Patterns of LMAT and Institutional Flows - Stock Traders Daily
Fri, 13 Feb 2026
A Look At LeMaitre Vascular (LMAT) Valuation After Recent Share Price Move And Mixed Return Profile - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 23 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 7.9 (%) |
| Held by Institutions | 95.2 (%) |
| Shares Short | 1,230 (K) |
| Shares Short P.Month | 1,130 (K) |
| EPS | 2.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.7 |
| Profit Margin | 22.1 % |
| Operating Margin | 25.4 % |
| Return on Assets (ttm) | 7.9 % |
| Return on Equity (ttm) | 15 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 7.53 |
| Sales Per Share | 10.61 |
| EBITDA (p.s.) | 3.18 |
| Qtrly Earnings Growth | 53.5 % |
| Operating Cash Flow | 73 (M) |
| Levered Free Cash Flow | 45 (M) |
| PE Ratio | 40.06 |
| PEG Ratio | 0 |
| Price to Book value | 5.56 |
| Price to Sales | 8.75 |
| Price to Cash Flow | 28.77 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|